Is it possible to build an ideal portfolio, one that perfectly balances risk and reward? In this talk, world-renowned MIT economist and financial scholar Andrew Lo, director of the MIT Laboratory for Financial Engineering, shares profound insights he learned from the world’s most prominent figures in the finance world, whom he profiled in his latest book “In Pursuit of the Perfect Portfolio.” He covers such areas as effective diversification, passive versus active investment, security selection and market timing, foreign versus domestic investments, derivative securities, nontraditional assets, irrational investing, and more. Acknowledging that the perfect portfolio is ultimately a moving target based on individual age and stage in life, market conditions, and short- and long-term goals, he explains why the fundamental principles for success remain constant in spite of changing market conditions.
“Finance can be tremendously powerful when used properly, but it can be a dangerous weapon if incorrectly applied,” warns world-renowned MIT economist and financial scholar Andrew Lo, director of the MIT Laboratory for Financial Engineering. Drawing from his deep research, he discusses his framework for quantitatively measuring the financial reward, or cost, of impact investing, including socially responsible investing (SRI) and environmental, social and governance (ESG) issues. Using real world examples, he illustrates how the framework can be applied in such diverse areas as biotech venture philanthropy, “sin” stocks, ESG and “meme” stocks like GameStop.
Nonprofits routinely shoulder the burden of raising funds to fight diseases like cancer and many other life-altering or life-threatening diseases. But what drives corporate investment in potential cures? Profit or purpose? Drawing from his ongoing research, world-renowned MIT economist and financial scholar Andrew Lo, director of the MIT Laboratory for Financial Engineering, discusses the most pressing medical challenges of our time, why so many potential innovations and cures lack funding, and the ethics of drug pricing policies. Inspired by his own family struggles with gaining access to cancer treatments, he highlights the urgent need to bridge the gap between science and finance and explains how health care institutions, drug companies, vaccine makers and biotech founders can improve patient outcomes as well as their bottom lines by letting science drive investment—not vice versa—so that everybody wins.
We are happy to assist you with your interest in booking a speaker or celebrity for your event, your organization, and the type of talent you would like to secure, and an agent will be in touch shortly.
Fill out the form below to or call us at 1-800-698-2536 if need immediate assistance.
We respond to most inquiries within 4 hours. Under special circumstances, it may take up to 24 hours.
This website is a resource for event professionals and strives to provide the most comprehensive catalog of thought leaders and industry experts to consider for speaking engagements. A listing or profile on this website does not imply an agency affiliation or endorsement by the talent.
All American Entertainment (AAE) exclusively represents the interests of talent buyers, and does not claim to be the agency or management for any speaker or artist on this site. AAE is a talent booking agency for paid events only. We do not handle requests for donation of time or media requests for interviews, and cannot provide celebrity contact information.